Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Oct-19 2:10 PM View:  | Azoy Alexander Chief Financial Officer | Sienna Biopharmaceuticals, ... (SNNA) | 02-Oct-19 | Payment of Exercise | 2,396 | $0.23 | $551.08 | (2%) 105.95K to 103.55K | |
| 08-Aug-19 4:42 PM View: | Azoy Alexander Chief Financial Officer | Sienna Biopharmaceuticals, ... (SNNA) | 06-Aug-19 | Grant | 70,000 | -- | -- | 195% 35.95K to 105.95K | |
| 08-Aug-19 4:40 PM View: | Lizzul Paul F. Chief Medical Officer | Sienna Biopharmaceuticals, ... (SNNA) | 06-Aug-19 | Grant | 55,000 | -- | -- | 36% 152.04K to 207.04K | |
| 08-Aug-19 4:38 PM View: | Beddingfield III Frederick President & CEO Director | Sienna Biopharmaceuticals, ... (SNNA) | 06-Aug-19 | Grant | 150,000 | -- | -- | 16% 930.21K to 1.08M | |
| 08-Aug-19 4:44 PM View: | Andrews Timothy K. General Counsel & Secretary | Sienna Biopharmaceuticals, ... (SNNA) | 06-Aug-19 | Grant | 50,000 | -- | -- | 41% 120.56K to 170.56K | |
| 03-Jul-19 1:42 PM View: | Andrews Timothy K. General Counsel & Secretary | Sienna Biopharmaceuticals, ... (SNNA) | 02-Jul-19 | Payment of Exercise | 4,095 | $0.76 | $3,112.20 | (3%) 124.65K to 120.56K | |
| 03-Jul-19 1:47 PM View: | Stroehmann Diane See Remarks | Sienna Biopharmaceuticals, ... (SNNA) | 02-Jul-19 | Payment of Exercise | 4,095 | $0.76 | $3,112.20 | (2%) 172.64K to 168.54K | |
| 03-Jul-19 1:36 PM View: | Azoy Alexander Chief Financial Officer | Sienna Biopharmaceuticals, ... (SNNA) | 02-Jul-19 | Payment of Exercise | 1,552 | $0.76 | $1,179.52 | (4%) 37.5K to 35.95K | |
| 03-Jul-19 1:39 PM View: | Lizzul Paul F. Chief Medical Officer | Sienna Biopharmaceuticals, ... (SNNA) | 02-Jul-19 | Payment of Exercise | 4,095 | $0.76 | $3,112.20 | (3%) 156.14K to 152.04K | |
| 03-Jul-19 1:35 PM View: | Beddingfield III Frederick President & CEO Director | Sienna Biopharmaceuticals, ... (SNNA) | 02-Jul-19 | Payment of Exercise | 17,063 | $0.76 | $12,967.90 | (2%) 947.28K to 930.21K | |
| 03-Apr-19 5:44 PM View: | Azoy Alexander Chief Financial Officer | Sienna Biopharmaceuticals, ... (SNNA) | 01-Apr-19 | Grant | 20,000 | -- | -- | 114% 17.5K to 37.5K | |
| 26-Feb-19 10:00 PM View: | More Robert J Director | Sienna Biopharmaceuticals, ... (SNNA) | 22-Feb-19 | Market Purchase | 100,000 | $2.50 | $250,000.00 | 64% 155.94K to 255.94K | 1% |
| 26-Feb-19 10:00 PM View: | Burow Kristina Director | Sienna Biopharmaceuticals, ... (SNNA) | 22-Feb-19 | Market Purchase | 2,165,800 | $2.50 | $5,414,500.00 | 60% 3.63M to 5.8M | 1% |
| 26-Feb-19 10:00 PM View: | Arch Venture Partners X, LLC 10% Owner | Sienna Biopharmaceuticals, ... (SNNA) | 22-Feb-19 | Market Purchase Duplicate | 2,165,800 | $2.50 | $5,414,500.00 | 296% 732.49K to 2.9M | 1% |
| 26-Feb-19 10:00 PM View: | Leonard Keith R Director | Sienna Biopharmaceuticals, ... (SNNA) | 22-Feb-19 | Market Purchase | 100,000 | $2.50 | $250,000.00 | 206% 48.48K to 148.48K | 1% |
| 26-Feb-19 10:00 PM View: | Beddingfield III Frederick President & CEO Director | Sienna Biopharmaceuticals, ... (SNNA) | 22-Feb-19 | Market Purchase | 40,000 | $2.50 | $100,000.00 | 4% 904.28K to 944.28K | 1% |
| 26-Feb-19 10:00 PM View: | Arch Venture Partners Viii,... 10% Owner | Sienna Biopharmaceuticals, ... (SNNA) | 22-Feb-19 | Market Purchase Duplicate | 2,165,800 | $2.50 | $5,414,500.00 | 296% 732.49K to 2.9M | 1% |
| 03-Jan-19 6:19 PM View: | Smither John W Chief Financial Officer | Sienna Biopharmaceuticals, ... (SNNA) | 01-Jan-19 | Grant | 45,000 | -- | -- | 123% 36.62K to 81.62K | |
| 03-Jan-19 6:13 PM View: | Andrews Timothy K. General Counsel & Secretary | Sienna Biopharmaceuticals, ... (SNNA) | 01-Jan-19 | Grant | 45,000 | -- | -- | 56% 79.65K to 124.65K | |
| 03-Jan-19 6:21 PM View: | Stroehmann Diane See Remarks | Sienna Biopharmaceuticals, ... (SNNA) | 01-Jan-19 | Grant | 45,000 | -- | -- | 35% 127.64K to 172.64K | |
| 03-Jan-19 6:16 PM View: | Lizzul Paul F. Chief Medical Officer | Sienna Biopharmaceuticals, ... (SNNA) | 01-Jan-19 | Grant | 45,000 | -- | -- | 42% 108.14K to 153.14K | |
| 03-Jan-19 6:11 PM View: | Beddingfield III Frederick President & CEO Director | Sienna Biopharmaceuticals, ... (SNNA) | 01-Jan-19 | Grant | 187,500 | -- | -- | 26% 716.78K to 904.28K | |
| 21-May-18 9:05 AM View: | Beddingfield III Frederick President & CEO Director | Sienna Biopharmaceuticals, ... (SNNA) | 17-May-18 | Acquisition (other) | 47,594 | -- | -- | 7% 694.42K to 742.01K | |
| 02-May-18 7:54 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 30-Apr-18 | Market Sale (Planned) | 100 | $20.00 | $2,000.00 | (< 1%) 571.09K to 570.99K | 85% |
| 25-Apr-18 7:21 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 25-Apr-18 | Market Sale (Planned) | 300 | $20.00 | $6,000.00 | (< 1%) 571.39K to 571.09K | 85% |
| 25-Apr-18 7:21 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 24-Apr-18 | Market Sale (Planned) | 150 | $20.00 | $3,000.00 | (< 1%) 571.54K to 571.39K | 85% |
| 25-Apr-18 7:21 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 23-Apr-18 | Market Sale (Planned) | 525 | $20.00 | $10,500.00 | (< 1%) 572.07K to 571.54K | 85% |
| 19-Apr-18 6:00 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 18-Apr-18 | Market Sale (Planned) | 15,810 | $20.09 | $317,599.00 | (3%) 587.88K to 572.07K | 85% |
| 19-Apr-18 6:00 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 17-Apr-18 | Market Sale (Planned) | 2,201 | $20.00 | $44,020.00 | (< 1%) 590.08K to 587.88K | 85% |
| 12-Apr-18 6:45 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 10-Apr-18 | Market Sale (Planned) | 3,779 | $20.02 | $75,640.80 | (< 1%) 593.86K to 590.08K | 85% |
| 09-Apr-18 7:18 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 09-Apr-18 | Market Sale (Planned) | 2,824 | $20.00 | $56,480.00 | (< 1%) 596.68K to 593.86K | 85% |
| 09-Apr-18 7:18 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 05-Apr-18 | Market Sale (Planned) | 5,386 | $20.00 | $107,725.00 | (< 1%) 602.07K to 596.68K | 85% |
| 29-Mar-18 8:50 PM View: | More Robert J Director | Sienna Biopharmaceuticals, ... (SNNA) | 29-Mar-18 | Market Sale | 14,429 | $18.78 | $270,977.00 | (7%) 193.25K to 178.82K | 84% |
| 29-Mar-18 8:50 PM View: | More Robert J Director | Sienna Biopharmaceuticals, ... (SNNA) | 28-Mar-18 | Market Sale | 10,000 | $18.84 | $188,400.00 | (5%) 203.25K to 193.25K | 84% |
| 20-Mar-18 7:00 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 19-Mar-18 | Market Sale (Planned) | 5,876 | $20.00 | $117,520.00 | (< 1%) 607.94K to 602.07K | 85% |
| 14-Mar-18 7:13 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 12-Mar-18 | Market Sale (Planned) | 3,452 | $20.11 | $69,429.00 | (< 1%) 611.39K to 607.94K | 85% |
| 09-Mar-18 7:00 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 09-Mar-18 | Market Sale (Planned) | 2,438 | $20.01 | $48,784.10 | (< 1%) 613.83K to 611.39K | 85% |
| 09-Mar-18 7:00 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 08-Mar-18 | Market Sale (Planned) | 14,530 | $20.03 | $291,097.00 | (2%) 628.36K to 613.83K | 85% |
| 09-Mar-18 7:00 PM View: | Harris Todd Head of Corporate Development Director | Sienna Biopharmaceuticals, ... (SNNA) | 07-Mar-18 | Market Sale (Planned) | 3,704 | $20.00 | $74,080.00 | (< 1%) 632.07K to 628.36K | 85% |
| 19-Sep-17 11:56 AM View: | Fenton Dennis M Director | Sienna Biopharmaceuticals, ... (SNNA) | 18-Sep-17 | Market Purchase | 1,250 | $22.96 | $28,697.90 | 100% 0 to 1.25K | (87%) |
| 01-Aug-17 4:22 PM View: | Leonard Keith R Director | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Purchase | 16,700 | $15.00 | $250,500.00 | 53% 31.78K to 48.48K | |
| 01-Aug-17 4:23 PM View: | Lizzul Paul F. Chief Medical Officer | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Purchase | 10,000 | $15.00 | $150,000.00 | 11% 95.19K to 105.19K | |
| 01-Aug-17 4:26 PM View: | Peterson Richard D Chief Financial Officer | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Purchase | 7,000 | $15.00 | $105,000.00 | 100% 0 to 7.0K | |
| 01-Aug-17 4:30 PM View: | Arch Venture Partners Viii,... 10% Owner | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Conversion Duplicate | 3,633,070 | -- | -- | 100% 0 to 3.63M | |
| 01-Aug-17 4:23 PM View: | Lizzul Paul F. Chief Medical Officer | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Conversion | 10,557 | -- | -- | 12% 84.63K to 95.19K | |
| 01-Aug-17 4:19 PM View: | Andrews Timothy K. General Counsel & Secretary | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Purchase | 15,000 | $15.00 | $225,000.00 | 29% 51.74K to 66.74K | |
| 01-Aug-17 4:24 PM View: | Mast Erle T Director | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Purchase | 6,700 | $15.00 | $100,500.00 | 100% 0 to 6.7K | |
| 01-Aug-17 4:20 PM View: | Beddingfield III Frederick President & CEO Director | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Conversion | 140,766 | -- | -- | 25% 553.65K to 694.42K | |
| 01-Aug-17 4:27 PM View: | Stroehmann Diane See Remarks | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Purchase | 7,000 | $15.00 | $105,000.00 | 6% 117.72K to 124.72K | |
| 01-Aug-17 4:22 PM View: | Leonard Keith R Director | Sienna Biopharmaceuticals, ... (SNNA) | 01-Aug-17 | Conversion | 31,784 | -- | -- | 100% 0 to 31.78K |
